ABUS vs EW
Arbutus Biopharma Corp (ABUS) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ABUS and EW stock pages for the full models.
Not investment advice.